Pharmaceutical Science Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About the Journal
    • Publisher
    • Aim and Scope
    • Ownership & Management
    • Indexing and Abstracting
    • Editorial Team
    • Privacy Statement
    • Journal History
  • Issues
    • Current
    • Archives
  • For Authors
    • Author Guidelines
    • Types of articles
    • Templates
    • Publication Fees
    • Peer Review Process
  • For Reviewers
    • Reviewers' Guidelines
    • Responcibility for Reviewres
  • Publication Ethics
    • Publication Ethics and Malpractice Statement
    • Code of Publishing Ethics
  • Policies and Process
    • Allegations of Misconduct
    • Article Processing Charge (APC)
    • Advertisement and Marketing
    • Archiving
    • Article Withdrawal & Retraction Policy
    • Conflict of Interest
    • Copyright Notice
    • Complaints Policy
    • Editorial Policies
    • Open Access Policy
    • Peer-Review Policy
    • Post- Publication Discussions and Corrections Policy
    • Principles of Transparency
    • Publication Policy
    • Repository
    • Using Artificial Intelligence (AI) Plicies
  • New Submission
  • FAQ
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

Esfand 2018

Formulation, Characterization and Optimization of Transferosomal Bovine Lactoferrin as a Novel Non-Invasive Topical Treatment for Genital Warts Caused by Human Papiluma Virus (HPV)

  • Naghmeh Hadidi
  • Mostafa Saffari
  • Haniyeh Rabiee
  • Ramin Ramezani Kalmer

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 Esfand 2018 , Page 46-47
https://doi.org/10.22037/ipa.v1i1.19999 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Human papilloma virus (HPV) causes common warts, laryngeal papilloma and genital condylomata and might lead to development of cervical cancer. Lactoferrin (LF), a member of the transferrin family, is a bi-globular protein and has antiviral activity against HPV-16.  LF is an important player in the defense against pathogenic microorganisms and has also shown to have activity against several viruses including herpesvirus, adenovirus, rotavirus and poliovirus.  Bovine LF has been reported to be a more potent inhibitor of HPV entry than human LF. The goal of the present study was to formulate, evaluate and optimize transfersomal vesicles as a transdermal drug delivery system for the lactoferrin which assumed to be a suitable non-invasive transdermal delivery system for treatment of genital warts.

Methods and Results: Transfersomes have been prepared by two methods of reverse phase evaporation and thin film hydration with different ratios of cholesterol: lecithin: DOTAP in the presence of SDS or Tween 80. The transferosomes were then evaluated regarding size, polydispersity and LF loading.  In vitro release studies in pH 5.3, stability evaluation in 4°c and 24°c and TEM imaging has been performed on optimized transferosomal lactoferrin. The optimized transferosomes were found to have 100 nm sizes with good PDI and encapsulation efficiency of 91% for lactoferrin as well as sustained release of lactoferrin during 24 hours. It was shown that unlike lactoferinn which should be stored in cold temperature, transferosomal lactoferrin would be stable in cool conditions.

Conclusions:

The elastic vesicular systems like transferosomes are one of the most controversial methods for transdermal delivery of active substances specially macromolecules and proteins. It was found that transferosomes would be ideal nano carriers with high loading efficiency and size uniformity as well as improving stability of lactoferrin. Further study is needed to investigate its efficacy in treatment of HPV caused genital warts and its viral inhibitory function.

Keywords:
  • Optimization, Transferosomal, Bovine Lactoferrin, Human Papiluma Virus (HPV)
  • PDF

How to Cite

Hadidi, N., Saffari, M., Rabiee, H., & Ramezani Kalmer, R. (2018). Formulation, Characterization and Optimization of Transferosomal Bovine Lactoferrin as a Novel Non-Invasive Topical Treatment for Genital Warts Caused by Human Papiluma Virus (HPV). International Pharmacy Acta, 1(1), 46–47. https://doi.org/10.22037/ipa.v1i1.19999
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 441 times
  • PDF Downloaded: 230 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus